Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7463 | 1364 | 37.1 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
1363 | 2 | TIRAPAZAMINE//DT DIAPHORASE//BIOREDUCTIVE DRUGS | 8244 |
7463 | 1 | NQO1//DT DIAPHORASE//EO9 | 1364 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NQO1 | authKW | 1264995 | 11% | 39% | 145 |
2 | DT DIAPHORASE | authKW | 1259257 | 8% | 49% | 114 |
3 | EO9 | authKW | 581394 | 2% | 84% | 31 |
4 | RH1 | authKW | 251823 | 1% | 75% | 15 |
5 | NQO2 | authKW | 248806 | 1% | 65% | 17 |
6 | NADPH QUINONE OXIDOREDUCTASE 1 | authKW | 222113 | 2% | 35% | 28 |
7 | INDOLEQUINONE | authKW | 182799 | 1% | 58% | 14 |
8 | DICOUMAROL | authKW | 173162 | 2% | 37% | 21 |
9 | AZIRIDINYLBENZOQUINONES | authKW | 164832 | 1% | 82% | 9 |
10 | NQO1 POLYMORPHISM | authKW | 156695 | 1% | 100% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 3487 | 27% | 0% | 372 |
2 | Biochemistry & Molecular Biology | 1838 | 33% | 0% | 447 |
3 | Pharmacology & Pharmacy | 1371 | 20% | 0% | 278 |
4 | Toxicology | 1064 | 9% | 0% | 123 |
5 | Chemistry, Medicinal | 702 | 7% | 0% | 101 |
6 | Biophysics | 519 | 8% | 0% | 110 |
7 | Endocrinology & Metabolism | 54 | 4% | 0% | 51 |
8 | Chemistry, Organic | 32 | 4% | 0% | 54 |
9 | Cell Biology | 26 | 4% | 0% | 61 |
10 | Biochemical Research Methods | 15 | 2% | 0% | 29 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GRP EXPT RADIAT ONCOL | 44770 | 0% | 100% | 2 |
2 | MED ONCOL CRC | 29845 | 0% | 67% | 2 |
3 | ZABLOCKI VAMC | 29845 | 0% | 67% | 2 |
4 | PHARMACEUT SCI KAGAWA | 26641 | 0% | 24% | 5 |
5 | 29 39 BRUNSWICK SQ | 22385 | 0% | 100% | 1 |
6 | AFFAIRS HOSP 4 | 22385 | 0% | 100% | 1 |
7 | ANHUI PROV HEPATOPANCREATOBILIARY | 22385 | 0% | 100% | 1 |
8 | BIOMED SCI BIOSCI BIOTECHNOL | 22385 | 0% | 100% | 1 |
9 | BLOOMBERG PUBL HLTH PHARMACOL MOL SCI | 22385 | 0% | 100% | 1 |
10 | BRADFORD TEACHING HOSP FDN HLTH SERV TRUST | 22385 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEMICA SCRIPTA | 6404 | 1% | 2% | 17 |
2 | CANCER TREATMENT REPORTS | 6310 | 2% | 1% | 25 |
3 | BIOCHEMICAL PHARMACOLOGY | 5523 | 5% | 0% | 68 |
4 | CHEMICO-BIOLOGICAL INTERACTIONS | 4265 | 2% | 1% | 33 |
5 | FREE RADICAL BIOLOGY AND MEDICINE | 4116 | 3% | 0% | 40 |
6 | ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 3225 | 4% | 0% | 50 |
7 | PHARMACOGENETICS | 2845 | 1% | 1% | 11 |
8 | ANTI-CANCER DRUG DESIGN | 2269 | 1% | 1% | 8 |
9 | ADVANCES IN FREE RADICAL BIOLOGY AND MEDICINE | 2033 | 0% | 9% | 1 |
10 | CANCER RESEARCH | 1982 | 4% | 0% | 60 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NQO1 | 1264995 | 11% | 39% | 145 | Search NQO1 | Search NQO1 |
2 | DT DIAPHORASE | 1259257 | 8% | 49% | 114 | Search DT+DIAPHORASE | Search DT+DIAPHORASE |
3 | EO9 | 581394 | 2% | 84% | 31 | Search EO9 | Search EO9 |
4 | RH1 | 251823 | 1% | 75% | 15 | Search RH1 | Search RH1 |
5 | NQO2 | 248806 | 1% | 65% | 17 | Search NQO2 | Search NQO2 |
6 | NADPH QUINONE OXIDOREDUCTASE 1 | 222113 | 2% | 35% | 28 | Search NADPH+QUINONE+OXIDOREDUCTASE+1 | Search NADPH+QUINONE+OXIDOREDUCTASE+1 |
7 | INDOLEQUINONE | 182799 | 1% | 58% | 14 | Search INDOLEQUINONE | Search INDOLEQUINONE |
8 | DICOUMAROL | 173162 | 2% | 37% | 21 | Search DICOUMAROL | Search DICOUMAROL |
9 | AZIRIDINYLBENZOQUINONES | 164832 | 1% | 82% | 9 | Search AZIRIDINYLBENZOQUINONES | Search AZIRIDINYLBENZOQUINONES |
10 | NQO1 POLYMORPHISM | 156695 | 1% | 100% | 7 | Search NQO1+POLYMORPHISM | Search NQO1+POLYMORPHISM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PEY, AL , MEGARITY, CF , MEDINA-CARMONA, E , TIMSON, DJ , (2016) NATURAL SMALL MOLECULES AS STABILIZERS AND ACTIVATORS OF CANCER-ASSOCIATED NQO1 POLYMORPHISMS.CURRENT DRUG TARGETS. VOL. 17. ISSUE 13. P. 1506 -1514 | 66 | 80% | 0 |
2 | DANSON, S , WARD, TH , BUTLER, J , RANSON, M , (2004) DT-DIAPHORASE: A TARGET FOR NEW ANTICANCER DRUGS.CANCER TREATMENT REVIEWS. VOL. 30. ISSUE 5. P. 437-449 | 89 | 68% | 93 |
3 | ROSS, D , SIEGEL, D , (2004) NAD(P)H : QUINONE OXIDOREDUCTASE 1 (NQO1, DT-DIAPHORASE), FUNCTIONS AND PHARMACOGENCTICS.QUINONES AND QUINONE ENZYMES, PT B. VOL. 382. ISSUE . P. 115-144 | 80 | 62% | 145 |
4 | KEPA, JK , WINSKI, SL , BEALL, HD , ANWAR, A , SIEGEL, D , ROSS, D , (2000) NAD(P)H : QUINONE OXIDOREDUCTASE 1 (NQO1): CHEMOPROTECTION, BIOACTIVATION, GENE REGULATION AND GENETIC POLYMORPHISMS.CHEMICO-BIOLOGICAL INTERACTIONS. VOL. 129. ISSUE 1-2. P. 77 -97 | 73 | 57% | 355 |
5 | COLUCCI, MA , MOODY, CJ , COUCH, GD , (2008) NATURAL AND SYNTHETIC QUINONES AND THEIR REDUCTION BY THE QUINONE REDUCTASE ENZYME NQO1: FROM SYNTHETIC ORGANIC CHEMISTRY TO COMPOUNDS WITH ANTICANCER POTENTIAL.ORGANIC & BIOMOLECULAR CHEMISTRY. VOL. 6. ISSUE 4. P. 637 -656 | 59 | 68% | 64 |
6 | PHILLIPS, RM , HENDRIKS, HR , PETERS, GJ , (2013) EO9 (APAZIQUONE): FROM THE CLINIC TO THE LABORATORY AND BACK AGAIN.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 168. ISSUE 1. P. 11-18 | 48 | 67% | 18 |
7 | GUTIERREZ, PL , (2000) THE ROLE OF NAD(P)H OXIDOREDUCTASE (DT-DIAPHORASE) IN THE BIOACTIVATION OF QUINONE-CONTAINING ANTITUMOR AGENTS: A REVIEW.FREE RADICAL BIOLOGY AND MEDICINE. VOL. 29. ISSUE 3-4. P. 263 -275 | 63 | 72% | 66 |
8 | CADENAS, E , (1995) ANTIOXIDANT AND PROOXIDANT FUNCTIONS OF DT-DIAPHORASE IN QUINONE METABOLISM.BIOCHEMICAL PHARMACOLOGY. VOL. 49. ISSUE 2. P. 127-140 | 73 | 61% | 225 |
9 | OH, ET , PARK, HJ , (2015) IMPLICATIONS OF NQO1 IN CANCER THERAPY.BMB REPORTS. VOL. 48. ISSUE 11. P. 609 -617 | 50 | 62% | 4 |
10 | ROSS, D , (2004) QUINONE REDUCTASES MULTITASKING IN THE METABOLIC WORLD.DRUG METABOLISM REVIEWS. VOL. 36. ISSUE 3-4. P. 639 -654 | 58 | 64% | 111 |
Classes with closest relation at Level 1 |